KLSE: KPJ (5878)       KPJ HEALTHCARE BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
1.03   -0.01 (0.96%)  1.02 - 1.04  8,598,900
Analyze this stock with MQ Trader system


Market Cap: 4,562 Million
NOSH: 4,429 Million
Avg Volume (4 weeks):10,396,395
4 Weeks Range:1.00 - 1.10
4 Weeks Price Volatility (%):
52 Weeks Range:0.84 - 1.17
52 Weeks Price Volatility (%):
Average Price Target: 1.17
Price Target Upside/Downside: +0.14

Financial Highlight

Latest Quarter | Ann. Date 31-Dec-2018 [#4]  |  19-Feb-2019
Next QR | Est. Ann. Date: 31-Mar-2019  |  30-May-2019
T4Q P/E | EY: 25.42  |  3.93%
T4Q DY | Payout %: 1.92%  |  48.77%
T4Q NAPS | P/NAPS: 0.4424  |  2.33
T4Q NP Margin | ROE: 5.63%  |  9.16%


Date Subject
21-Feb-2019 柔佛医药保健 今年延续增长势头
20-Feb-2019 KPJ Healthcare - Falling short of target
20-Feb-2019 KPJ Healthcare - a Solid 2018
20-Feb-2019 KPJ Healthcare - FY18 core net profit higher by 5.6%
20-Feb-2019 KPJ Healthcare Berhad - Strong Support From Domestic Operation
20-Feb-2019 KPJ Healthcare Berhad - Exceeding Expectations
20-Feb-2019 Mplus Market Pulse - 20 Feb 2019
20-Feb-2019 KPJ Healthcare - Oldwives Say That Hiccups Result in Growth
20-Feb-2019 KPJ Healthcare - FY18 Within Expectations
17-Feb-2019 [转贴] [Facebook live:浅谈KPJ healthCare bhd (KPJ)] - James的股票投资James Share Investing
13-Feb-2019 M+ Online Technical Focus - 13 Feb 2019
12-Feb-2019 大行出招.猪年价值股守成
29-Jan-2019 Trading Stocks - KPJ Healthcare
24-Jan-2019 Daily Market Update - 24 Jan 2019 (KPJ, HEVEA)
23-Jan-2019 KPJ Healthcare Bhd - Keeping Up With KPJ
04-Jan-2019 Healthcare - Expensive Dose
27-Dec-2018 Healthcare - Healthy prospects but fully valued
13-Dec-2018 柔佛医药保健 B40保健基金受益者
11-Dec-2018 KPJ Healthcare - Catalysed by the B40
11-Dec-2018 KPJ Healthcare - Catalysed by the B40

Business Background

KPJ Healthcare Berhad provides private healthcare services. The group has assets in the form of hospitals and retirement centers in Malaysia, Indonesia, Thailand, Bangladesh, and Australia. KPJ's operations include a variety of surgical disciplines, medical specialties, and hospital clinical services & facilities. The revenue generating segments include hospital & healthcare, aged care, and wellness. The wellness segment supports customers who wish to embrace a healthier lifestyle regime. The hospital & healthcare segment is responsible for generating a majority of revenue. Most of the group's hospitals are spread across Malaysia. Therefore, most of revenue is earned in Malaysia.
Trade this stock with T+7 trading account. Find out more.

  3 people like this.
Feizal Mazlan Good to buy when the price fall down below than RM1.
13/11/2018 11:23
Money122 It seems like to rebound higher
14/11/2018 12:00
mm310 epf keeps disposing...
14/11/2018 14:00
Vincent_8316 mm310, Keep disposing meant to RUN~~~
14/11/2018 14:07
Gabriel Khoo Need fund to convert warrant
15/11/2018 01:32
5354_ Div 0.5 sen(every qtr?) a lot kah at 1.08?
16/11/2018 04:11
bowman It's RM5 for every 1,000. Postpone the Porche booking
19/11/2018 08:25
Fiona60 Potential counter, As the market isn't stable so it is better to hold if you entered in it. To get daily stocks updates with Target , Technical & Fundamental analysis and short term trade details Join my group whatsap at ( 60 1157 96 8095 )
20/11/2018 19:27
Wong Wei Dividen so little sial RM 5 cannot reinvest also !!
26/11/2018 17:12
Junqi Interesting to note, PB whicn is bearish about KPJ is most bullish about IHH.
Kenanga most bullish about KPJ ix most bearish about IHH.
As an unsofisticated KPJ shareholder, I only look at PE and dividend yield, KPJ beats IHH
hands down
01/12/2018 09:36
RocketRider Keep on share buyback, something is brewing?
07/12/2018 21:55
necro warran almost expired,value almost 0...so must maintain price then onli warrant value not 0
10/12/2018 17:08
necro see announcement 60Millions warrant convert @ RM1.01 while warrant RM0.025 total cost RM1.035 current price RM1.06...walao must be bonus issue + new warrant in 3-5 years time frame
11/12/2018 15:56
shpg22 Poor balance sheet + Poor dividend + Poor EPS growth + Poor FCF = Super Overpriced.
Downgrade fair price to 0.50
19/12/2018 13:32
Shadows When is KPJ Manjung going to finish with it new extension? No one is working for past few months.
26/12/2018 22:08
Catherine17 How to convert WB? I am a direct account
27/12/2018 11:19
Penguin88 KPJ business is recession proof and resilient. I think it will be a good chance now to accumulate due to share price weakness.
04/01/2019 12:26
shpg22 Yes it is recession proof. But u should be worry more on its poor management.
05/01/2019 01:14
Gabriel Khoo Wait the expiry of warrant no worry now
05/01/2019 18:40
necro poor management?..dick head your poor management...talk only valuation don't know la u shpg22...name also talk cock
07/01/2019 09:55
shpg22 When ppl get too attached to a certain company (eg staff) they can get very emotionally when come to negative opinion. IHH or even TMCLIFE is a better value than KPJ
07/01/2019 10:04
aminaruto Clearly they do not care of investors. Let the share slip despite good fundamentals. Lesson learnt never invest in counters related to Jcorp. Loss money got nothing. Trading can la. Got some popit the cow fast run from sluggish kpj!!
07/01/2019 10:44
Junqi Kpj trading about the conversion price of its warrant of 1.01
Not really worth clnverting
09/01/2019 09:13
Juan_Hardiez Watch closely KPJ. The share is already oversold and the price always shoots up eventhough the macd is buy cross below zero. The Kpj-cs is only 4.5 sen now. I’m targeting 10 sen
21/01/2019 08:41
hoplanner Very stable at 1.07
24/01/2019 16:28
Money122 Now in up trend
27/01/2019 10:09
BrunoMars Post removed. Why?
27/01/2019 10:09
Money122 1.50 coming
27/01/2019 10:10
Money122 Tp 10.0 in long term
30/01/2019 04:31
kyy_superinvestor A bunch of sohai buy high pe stock here ...tut tut
30/01/2019 22:18
bowman Ex-rights on Jan 23. So technically, there is more certainty in sharebase. ie. no more conversion to dilute existing share base. This augurs well for this and we can expect a rise pretty soon in prices. In other words, it should be in uptrend, all things considered
31/01/2019 09:02
Junqi There are still sizeable ESOS to be converted
at 0.91 cts
01/02/2019 16:00
hoplanner Are you one of the staff?
02/02/2019 15:30
commonsense KPJ has a proven track record in delivering both revenue and profit growth to its shareholders which is mainly derive from the increase of numbers from both the hospital (from only 19 in 2009 to now 25 hospitals as of early 2019) and available beds (from 2,503 to now 3,060).

Between FY09 to FY17 revenue grew from RM1,456mil to RM3,224mil (which is an average growth rate of 10.5%) while profit to shareholders grew from RM111mil to RM162mil (a slower average growth rate of 4.9%). 9m18 result fared a lot better with KPJ delivering a profit of around RM126mil during the period vs 9m17 profit of only RM101mil.

The issue with KPJ is not on the company’s business outlook but mainly on its very rich valuation. The 6 analysts covering the stock has an average profit to shareholder of RM187mil for FY18 and RM203mil in FY19. At the current price, this would mean that KPJ is already trading at a high valuation of 25.3x trailing PE and 23.3x fwd PE. At this valuation, most of the optimisms/ growth of the company would have already been baked into the share price.

If you are looking to diversify your portfolio outside of KPJ (relatively high valuation), I would recommend you to look at MBMR.

MBMR is a direct proxy to Perodua via its 22.6% interest in the company. Valuation is cheap at only 6.9x PE (based on target FY18 profit of RM145mil. 9m profit is already RM106mil). PB is low at only 0.7x BV. 4Q18 results is expected to be higher than 3Q18 and last year's 4Q17.

FY19 growth will be driven by the still high demand of the new Myvi and the newly launched SUV Aruz and also the newly revamp Alza in 2H19. The recent announcement of closure and potential disposal of the loss-making alloy wheel manufacturing business alone is expected to boost the company’s profit by an additional RM20mil. I am projecting a profit to shareholder of RM170 mil for FY19 which at the current price values MBMR at only 5.9x PE.

Please go through the analyst reports (https://klse.i3investor.com/servlets/stk/pt/5983.jsp) and do your own analysis before making any decisions. There are 8 analysts in total covering the stock with most of them having a TP of above RM3 (all have a buy rating). The average TP for the 8 analysts is around RM3.50.

Good luck.
05/02/2019 17:42
James Ng https://klse.i3investor.com/blogs/general/193728.jsp
[转贴] [Facebook live:浅谈KPJ healthCare bhd (KPJ)] - James的股票投资James Share Investing
17/02/2019 12:55
chanph Qtr looks ok
19/02/2019 19:36
shpg22 Qtr looks ok. Price is not ok. Valuation highest among healthcare provider.
19/02/2019 22:31
Junqi shpg22. Look at IHH PE 100, TMC PE 40. KPJ PE 28.
Highest valuation?.
20/02/2019 08:51
shpg22 If its as simple as looking at the PE for valuation, everyone will be rich.
20/02/2019 09:54
Gabriel Khoo Shpg22 then what valuatio you mentioned here? Contradict?
21/02/2019 20:19
Penguin88 Previously EPF was selling aggressively and cap the price..hopefully now the price can perform after a good result
21/02/2019 22:32
shpg22 You need to look at all angles for valuation. Current P/E, P/B, future growth & DY historical div payout, earning, book, Share Dilution, FCF, Debt/equity, Liquidity etc. It is not as simple as looking at P/E or else the fools will be filthy rich.
26/02/2019 11:58
Junqi Someone forcing share price down
28/02/2019 19:10
Heavenly PUNTER yaya typical conspiracy theory, operator lah big shark lah, press price down want to accumulate more lah
28/02/2019 19:11
hoplanner Agree with Junqi. It happened a few times in the past 2 yrs. just recently it went down to 95sen and now the same cindy kate is conspiring. It an advantage to be big
01/03/2019 10:49
Junqi Million of shares traded everyday, and the price stays almost unchanged
So strange. Anyone can explain?
05/03/2019 14:46
Money122 I think it can trend higher
08/03/2019 10:47
witchjaz KUALA LUMPUR (March 15): UOB Kay Hian analyst Philip Ching Wern Wong upgraded the recommendation on KPJ Healthcare Bhd to buy from hold.

* Price target (PT) raised to RM1.22 from RM1.04, implies 17% increase. KPJ Healthcare average PT is RM1.18.

* KPJ Healthcare had 8 buys, 9 holds, 1 sell previously: Bloomberg data

* Analysts haven't changed their consensus one-year target price for the stock in the past six months. Forecasts range from 96 sen to RM1.35.
15/03/2019 12:27
Junqi More than 75 million shares changed hands yesterday and share price hardly moved
Some big holder selling. Could be LTH
There must also be willing buyers ?? Jcorp linked companies
16/03/2019 11:05
Irwan0655 Testing
17/03/2019 22:26


375  384  489  646 

Top 10 Active Counters
 SAPNRG 0.36-0.005 
 SAPNRG-WA 0.145+0.01 
 ORION 0.205+0.015 
 DESTINI 0.34+0.025 
 PUC 0.105-0.005 
 IRIS 0.15+0.01 
 APFT 0.02+0.005 
 ARMADA 0.20+0.01 
 HSI-C3V 0.125+0.02 
 DAYANG 1.62-0.09 
Partners & Brokers